Bharat Biotech sets equitable pricing for malaria vaccine Mosqivac

Bharat Biotech International Limited has announced an equitable pricing agreement with Gavi and UNICEF for Mosqivac, the world's first malaria vaccine RTS,S/AS01. This vaccine, originally developed by GSK, is now manufactured by Bharat Biotech, marking a significant step in making malaria prevention more accessible globally.

Originally published by gnews